Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Micronoma Wins Bio-IT World Innovative Practices Award
Micronoma, the first cancer detection biotech company to diagnose cancer at an early stage with microbiome-driven […]
SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer
CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI-data driven proteomics technology, […]
eTheRNA Immunotherapies Opens Office in Hong Kong to Support and Build on its Growing Activities in China and Broader Asia-Pacific
eTheRNA immunotherapies NV (‘eTheRNA’ or the ‘Company’), a clinical-stage company developing mRNA-based immunotherapies for the […]
Miiskin Makes Use of Augmented Reality for New Mole Sizing Feature
Miiskin has launched a new mole sizing feature that uses augmented reality technology to enable […]
Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization
Syneos Health® (Nasdaq:SYNH) and Aetion® announced a partnership to provide regulatory-grade data and analytics-driven solutions to advance […]
Healthera Announces Partnership with Alliance Healthcare to Drive Forward the Digital Agenda Within Community Pharmacies
Today, Healthera is pleased to announce a partnership with Alliance Healthcare. Alliance Healthcare is the […]
Juno Medical Raises $5.4M in Seed Financing to Reimagine Primary Care for the 99%
Juno Medical, the modern doctor’s office that’s designed for the 99%, today announces $5.4 million in seed […]
New Tool for Early Identification of COVID-19 Surges
Health systems could use data from routine clinical care to identify the onset of upcoming […]
FDA Clears NYU Langone Genome PACT
The U.S. Food and Drug Administration (FDA) has cleared for clinical lab use a gene […]
2021 BioTech Breakthrough Awards Program Opens for Nominations
BioTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies, and products […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more